Mazor Robotics (NSDQ:MZOR) said it plans to offer 2.4 million shares of stock at $17 apiece, for total proceeds of $40.8 million.
Reverse Medical lands CE Mark, 510(k) for brain catheters
Reverse Medical Corp. said it won CE Mark approval in the European Union and 510(k) clearance from the FDA for its ReVerse neurovascular microcatheter device.
The regulatory nods are for use in the neurological, peripheral and coronary vasculature for the infusion of diagnostic and therapeutic agents, according to a press release.
AngioDynamics wins CE Mark for AngioVac
AngioDynamics (NSDQ:ANGO) said it won CE Mark approval in the European Union for its AngioVac venous drainage cannula and cardiopulmonary bypass circuit.
Edwards Lifesciences gets in on $3M Series A tranche for Middle Peak Medical
Middle Peak Medical said it added $3 million from Edwards Lifesciences (NYSE:EW) and other investors to its Series A round, taking the total raise to $11 million.
C.R. Bard shifts jobs to upstate N.Y.
AdvaMed study: Medical devices are part of the solution, not the problem
Medical devices are not the cause of price variations in hospital care across the U.S., but rather are a part of the solution, according to medical device industry lobbying group AdvaMed.
“It is really clear in the evidence provided by these and other studies that medical devices are not the problem when it comes to rising healthcare costs. In fact, they’re a big part of the solution,” Biomet CEO & AdvaMed board member Jeff Binder said during a conference call today.
Nihon Kohden lands $27.5M U.S. Defense Dept. deal
The U.S. Defense Dept. extended its deal with Nihon Kohden (TYO:6849) for a 2nd year, the agency said last week.
Elekta’s new CEO is Nokia vet | Personnel Moves
Elekta (STO:EKTA B) said it named Niklas Savander, a former Nokia executive, as its new president & CEO. Savander is succeeding Tomas Puusepp, who will keep his seat on Stockholm-based company’s board.
IT’s Savander’s 1st venture into the medical device industry. His resume includes stints at Hewlett-Packard as well as Nokia, according to a press release.
NeuroMetrix falls despite narrowed Q3 losses
NeuroMetrix (NSDQ:NURO) shares lost more than 4% of their value yesterday after the medical device company reported a more than 25% sales slide during the 3rd quarter.
Varian Medical slides on missed Q4 earnings, slowing sales growth
Varian Medical (NYSE:VAR) finished fiscal 2013 ahead of Wall Street’s estimates, but investors still shaved nearly 7% from its share price yesterday.